Prof. Dr. Eberhard Hildt

Further involvements

• 28/03/2023

  • Poster
  • P 157

  Guanylate-binding protein 1 (GBP1) acts as an essential factor during hepatitis C virus (HCV) morphogenesis

   Host cell factors and modulation, Innate immunity
• 28/03/2023

  • Poster
  • P 349

  Multivesicular bodies and the hepatitis E virus life cycle – more than just release?

   Emerging viruses and zoonosis, Viral replication strategies 1 (RNA viruses)
• 28/03/2023

  • Poster
  • P 231

  Pim-kinase inhibitors as antivirals against SARS-CoV-2

   Host cell factors and modulation, SARS-CoV-2
• 28/03/2023

  • Poster
  • P 158

  The role of epidermal growth factor receptor in the viral life cycle of the hepatitis E virus

   Emerging viruses and zoonosis, Host cell factors and modulation
• 28/03/2023

  • Poster
  • P 159

  Genotype related impact of the hepatitis B virus protein HBx on mitochondrial dynamics and the functional role in associated signaling pathways

   Host cell factors and modulation, Viral pathogenesis and persistence
• 28/03/2023

  • Poster
  • P 147

  The folate antimetabolite methotrexate impairs replication of the SARS-CoV-2 wild-type virus and of variants of concern

   Epidemiology and public health
• 28/03/2023

  16:30 – 16:45 12 Min. 3 Min.

  • Abstract Talk
  • O 016

  Establishing genomic SARS-CoV-2 surveillance at the national level

   Diagnostic methods and tools
• 28/03/2023

  18:00 – 18:15 12 Min. 3 Min.

  • Abstract Talk
  • O 032

  (N)one size fits all: Genotype-matched analysis of different disease phases of chronic hepatitis B virus infection

   Clinical virology, Viral pathogenesis and persistence
• 30/03/2023

  09:30 – 09:45 12 Min. 3 Min.

  • Abstract Talk
  • O 083

  The selective TRPML2 agonist ML2-SA1 impairs Zika virus infection in vitro

   Antiviral therapy and resistance, Host cell factors and modulation
• 30/03/2023

  14:15 – 14:30 12 Min. 3 Min.

  • Abstract Talk
  • O 094

  Effect of HCV infection on Nrf1 activity

   Host cell factors and modulation, Innate immunity
• 31/03/2023

  11:30 – 11:45 12 Min. 3 Min.

  • Abstract Talk
  • O 118

  Rational design of a cell-permeable antigen presentation platform for needle-free vaccination

   Adaptive immunity, Vaccines